Amandine Hurbin

2.4k total citations
44 papers, 1.9k citations indexed

About

Amandine Hurbin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amandine Hurbin has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amandine Hurbin's work include Nanoplatforms for cancer theranostics (12 papers), HER2/EGFR in Cancer Research (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Amandine Hurbin is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), HER2/EGFR in Cancer Research (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Amandine Hurbin collaborates with scholars based in France, Germany and Spain. Amandine Hurbin's co-authors include Jean‐Luc Coll, Marie Favrot, Benoît Busser, Lucie Sancey, Élisabeth Brambilla, Laurence Dubrez, Véronique Josserand, Marie‐Christine Favrot, Alain Rabié and F. Moos and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Amandine Hurbin

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amandine Hurbin France	25	1.1k	429	333	236	189	44	1.9k
Hiroyuki Michiue Japan	27	1.3k 1.2×	315 0.7×	176 0.5×	147 0.6×	154 0.8×	66	2.5k
Khursheed Anwer United States	27	1.2k 1.1×	171 0.4×	103 0.3×	182 0.8×	135 0.7×	53	1.9k
Cornelia Brendel Germany	28	776 0.7×	598 1.4×	136 0.4×	92 0.4×	84 0.4×	82	2.6k
Joel G. Turner United States	27	1.5k 1.4×	818 1.9×	135 0.4×	109 0.5×	63 0.3×	75	3.3k
Mark R. Morgan United Kingdom	23	949 0.9×	202 0.5×	119 0.4×	247 1.0×	64 0.3×	42	2.2k
Claudia Seidel Germany	15	957 0.9×	605 1.4×	184 0.6×	743 3.1×	183 1.0×	17	2.2k
Satoru Ito Japan	21	848 0.8×	134 0.3×	277 0.8×	184 0.8×	62 0.3×	43	1.6k
Han Sheng Chiu Australia	16	1.7k 1.6×	231 0.5×	504 1.5×	494 2.1×	55 0.3×	30	2.2k
Daniela M. Dinulescu United States	24	1.9k 1.7×	1.1k 2.5×	251 0.8×	315 1.3×	391 2.1×	50	4.3k
Yiming Zhou China	24	1.4k 1.3×	425 1.0×	197 0.6×	117 0.5×	52 0.3×	74	2.5k

Countries citing papers authored by Amandine Hurbin

Since Specialization

Citations

This map shows the geographic impact of Amandine Hurbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amandine Hurbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amandine Hurbin more than expected).

Fields of papers citing papers by Amandine Hurbin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amandine Hurbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amandine Hurbin. The network helps show where Amandine Hurbin may publish in the future.

Co-authorship network of co-authors of Amandine Hurbin

This figure shows the co-authorship network connecting the top 25 collaborators of Amandine Hurbin. A scholar is included among the top collaborators of Amandine Hurbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amandine Hurbin. Amandine Hurbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jourdain, M., Lucie Sancey, Amandine Hurbin, et al.. (2025). Photodynamic drug delivery for cancer therapy: Designing liposomes for light-controlled release and enhanced drug efficacy. European Journal of Pharmaceutical Sciences. 213. 107221–107221.

Bouclier, Céline, Matthieu Simon, Guillaume Laconde, et al.. (2020). Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth. Theranostics. 10(5). 2008–2028. 16 indexed citations

Lehmann, Sylvain, Michel Sève, Laetitia Vanwonterghem, et al.. (2019). A large scale proteome analysis of the gefitinib primary resistance overcome by KDAC inhibition in KRAS mutated adenocarcinoma cells overexpressing amphiregulin. Journal of Proteomics. 195. 114–124. 11 indexed citations

Gauche, Cony, Silvia Mazzaferro, Laetitia Vanwonterghem, et al.. (2018). Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer. Journal of Controlled Release. 275. 117–128. 71 indexed citations

Vanwonterghem, Laetitia, Maxime Henry, Julien Vollaire, et al.. (2018). The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivo. Biochemical Pharmacology. 160. 1–13. 14 indexed citations

Aspord, Caroline, Corinne Leloup, Jérôme Kucharczak, et al.. (2017). Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model. Molecular Therapy. 25(2). 534–546. 19 indexed citations

Prunier, Chloé, Véronique Josserand, Julien Vollaire, et al.. (2016). LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers. Cancer Research. 76(12). 3541–3552. 27 indexed citations

Busser, Benoît, Laetitia Vanwonterghem, Murat Cokol, et al.. (2016). Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. OncoTargets and Therapy. Volume 9. 6843–6855. 29 indexed citations

Atallah, I., Maxime Henry, É. Reyt, et al.. (2015). Role of near-infrared fluorescence imaging in the resection of metastatic lymph nodes in an optimized orthotopic animal model of HNSCC. European Annals of Otorhinolaryngology Head and Neck Diseases. 132(6). 337–342. 11 indexed citations

10.

Audfray, Aymeric, Adrien Breiman, Amandine Hurbin, et al.. (2015). A Recombinant Fungal Lectin for Labeling Truncated Glycans on Human Cancer Cells. PLoS ONE. 10(6). e0128190–e0128190. 22 indexed citations

11.

Mazzaferro, Silvia, J. Lavaud, Laetitia Vanwonterghem, et al.. (2015). Targeting CD44 receptor-positive lung tumors using polysaccharide-based nanocarriers: Influence of nanoparticle size and administration route. Nanomedicine Nanotechnology Biology and Medicine. 12(4). 921–932. 53 indexed citations

12.

Atallah, I., et al.. (2014). Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans. European Archives of Oto-Rhino-Laryngology. 272(10). 2593–2600. 26 indexed citations

13.

Busser, Benoît, Élisabeth Brambilla, Marie Wislez, et al.. (2013). The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism. International Journal of Cancer. 134(11). 2560–2571. 48 indexed citations

14.

Hurbin, Amandine, Benoît Busser, Élisabeth Brambilla, et al.. (2010). 101: Identification of differential pathways in mucinous and non-mucinous subtypes of lung adenocarcinoma suggested new therapeutic strategies. Bulletin du Cancer. 97(1). S81–S82. 2 indexed citations

15.

Busser, Benoît, Lucie Sancey, Véronique Josserand, et al.. (2009). Amphiregulin Promotes Resistance to Gefitinib in NonSmall Cell Lung Cancer Cells by Regulating Ku70 Acetylation. Molecular Therapy. 18(3). 536–543. 40 indexed citations

16.

Busser, Benoît, et al.. (2006). 034 L’Amphiréguline : un facteur de résistance au gefitinib dans la lignée H358 de cancer du poumon non à petites cellules. Revue des Maladies Respiratoires. 23(5). 528–528.

17.

Hurbin, Amandine, Jean‐Luc Coll, Laurence Dubrez, et al.. (2005). Cooperation of Amphiregulin and Insulin-like Growth Factor-1 Inhibits Bax- and Bad-mediated Apoptosis via a Protein Kinase C-dependent Pathway in Non-small Cell Lung Cancer Cells. Journal of Biological Chemistry. 280(20). 19757–19767. 35 indexed citations

18.

Hurbin, Amandine, Laurence Dubrez, Jean‐Luc Coll, & Marie Favrot. (2003). Inhibition of Apoptosis by Amphiregulin via an Insulin‐like Growth Factor‐1 Receptor—Dependent Pathway in Non‐Small Cell Lung Cancer Cell Lines. Annals of the New York Academy of Sciences. 1010(1). 354–357. 48 indexed citations

19.

Hurbin, Amandine, Hélène Orcel, Gérard Alonso, F. Moos, & Alain Rabié. (2002). The Vasopressin Receptors Colocalize with Vasopressin in the Magnocellular Neurons of the Rat Supraoptic Nucleus and Are Modulated by Water Balance. Endocrinology. 143(2). 456–466. 63 indexed citations

20.

Brès, Vanessa, Amandine Hurbin, Anne Duvoid, et al.. (2000). Pharmacological characterization of volume‐sensitive, taurine permeable anion channels in rat supraoptic glial cells. British Journal of Pharmacology. 130(8). 1976–1982. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact